Eisai
4523.T
#2292
Rank
C$11.43 B
Marketcap
C$40.53
Share price
-1.20%
Change (1 day)
5.70%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2025 (TTM): C$1.17

According to Eisai's latest financial reports the company's current EPS (TTM) is C$1.20. an increase over its 2024 EPS that were of C$1.36.

EPS history for Eisai from 2000 to 2025

Annual EPS

Year EPS Change
2025C$1.5211.85%
2024C$1.36-32.63%
2023C$2.015.52%
2022C$1.91-74.01%
2021C$7.34-66.58%
2020C$21.9798.24%
2019C$11.0817.01%
2018C$9.4737.78%
2017C$6.87-27.62%
2016C$9.5035.33%
2015C$7.02-2.82%
2014C$7.22-27.66%
2013C$9.98-27.49%
2012C$13.77-12.67%
2011C$15.7788.08%
2010C$8.38-11.06%
2009C$9.43-390.15%
2008C-$3.25-127.78%
2007C$11.7011.78%
2006C$10.464.38%
2005C$10.037.4%
2004C$9.3443.03%
2003C$6.5325.09%
2002C$5.2252.67%
2001C$3.4269.76%
2000C$2.01